Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
N
Naderer, Odin
Chimerix, Inc.
054
:
The Effect of Moderate Hepatic Impairment on ONC201 (Dordaviprone) Pharmacokinetics
Odin Naderer
Favorite
143
:
The Effect of Severe Renal Impairment on ONC201 (Dordaviprone) Pharmacokinetics
Odin Naderer
Favorite
Nanah, Abdulaziz
Cytel
055
:
First-in-Human Population PKPD Modelling & Simulation of CUE-101: Preliminary Results
Abdulaziz Nanah
Favorite
Nanavati, Charvi
Pfizer Inc
071
:
Evaluation of Palbociclib & Combinatorial Chemotherapy Pharmacokinetics in Pediatric Patients With Recurrent or Refractory Solid Tumors
Charvi Nanavati
Favorite
Nguyen, May
Rutgers The State Univ of New Jersey
039
:
Incidence & Predictors of Stroke Mimic Amongst Patients Treated With Recombinant Tissue Plasminogen Activator: A Retrospective Comparison
May Nguyen
Favorite
Nguyen, Phuong
HaiPhong Univ of Medicine & Pharmacy
A003
:
Enhanced HLA-B*15:02 Screening Before Carbamazepine Therapy in Vietnam: Advancements in Real-Time PCR TaqMan Probe Procedure
Phuong Nguyen
Favorite
Nwabufo, Chukwunonso
University of Toronto
089
:
The Impact of COVID-19 Mediated Bidirectional Dysregulation of CYP3A4 on Systemic & Pulmonary Candidate Drug Concentrations
Chukwunonso Nwabufo
Favorite
